These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12644029)

  • 1. Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients.
    Bytzer P
    Am J Gastroenterol; 2003 Mar; 98(3 Suppl):S31-9. PubMed ID: 12644029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.
    Bardhan KD; Berghöfer P
    Digestion; 2007; 75 Suppl 1():87-100. PubMed ID: 17489037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children.
    Hassall E
    J Pediatr; 2005 Mar; 146(3 Suppl):S3-12. PubMed ID: 15758900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of gastroesophageal reflux disease.
    Pettit M
    Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux disease.
    Quigley EM
    Am J Gastroenterol; 2003 Mar; 98(3 Suppl):S24-30. PubMed ID: 12644028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabeprazole-based therapy in the management of symptomatic gastroesophageal reflux disease.
    Sloan S
    Am J Gastroenterol; 2003 Mar; 98(3 Suppl):S49-55. PubMed ID: 12644031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
    Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
    Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is gastroesophageal reflux disease really a life-long disease: do babies who regurgitate grow up to be adults with GERD complications?
    Gold BD
    Am J Gastroenterol; 2006 Mar; 101(3):641-4. PubMed ID: 16542297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and predictors of long-term outcome in patients undergoing open Nissen fundoplication for chronic gastroesophageal reflux.
    Pidoto RR; Fama' F; Giacobbe G; Gioffre' Florio MA; Cogliandolo A
    Am J Surg; 2006 Apr; 191(4):470-8. PubMed ID: 16531138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
    Haag S; Holtmann G
    Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis.
    Richter JE; Peura D; Benjamin SB; Joelsson B; Whipple J
    Arch Intern Med; 2000 Jun; 160(12):1810-6. PubMed ID: 10871975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).
    Pohle T; Domschke W
    Langenbecks Arch Surg; 2000 Aug; 385(5):317-23. PubMed ID: 11026702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture.
    Wetscher GJ; Glaser K; Gadenstaetter M; Profanter C; Hinder RA
    Am J Surg; 1999 Mar; 177(3):189-92. PubMed ID: 10219852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis.
    Robinson M; Fitzgerald S; Hegedus R; Murthy A; Jokubaitis L;
    Aliment Pharmacol Ther; 2002 Mar; 16(3):445-54. PubMed ID: 11876697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotherapy and surgery for GERD.
    Triadafilopoulos G
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2():S87-96. PubMed ID: 17575537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines on gastroesophageal reflux disease.
    Niaz SK; Quraishy MS; Taj MA; Abid S; Alam A; Nawaz AA; Ali Shah SH; Khan IM; Memon AR; Zuberi BF; Tayyab GN; Malik K; Mirza S; Abbas Z;
    J Pak Med Assoc; 2015 May; 65(5):532-41. PubMed ID: 26028389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroesophageal reflux disease in adults: pathophysiology, diagnosis, and management.
    Rex DK
    J Fam Pract; 1992 Dec; 35(6):673-81. PubMed ID: 1453152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.